Related Experiment Video

Updated: Mar 7, 2026

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

9.9K

IgM is Unable to Enhance Antibody Responses in Mice Lacking C1q or C3

A Sörman1, A Westin1, B Heyman1

  • 1Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Scandinavian Journal of Immunology
|February 21, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

11.0K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Related Experiment Videos

Last Updated: Mar 7, 2026

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

9.9K
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

11.0K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

85.1K
Overview
85.1K

Articles linked to this work by shared authors, journal, and citation graph.

FcµR and IgM-Mediated Complement Activation Cooperate to Enhance Humoral Immunity.

European journal of immunology·2025

Life-threatening antibodies: The discovery of anaphylaxis.

Immunological reviews·2024

Antibody feedback regulation.

Immunological reviews·2024

IgG-mediated suppression of antibody responses: Hiding or snatching epitopes?

Scandinavian journal of immunology·2020

Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons.

The Journal of experimental medicine·2019

Some health physics aspects of working with 203Hg in university research.

Health physics·2001

Nuclear Factor Kappa B (NF-κB)1 and NF-κB2 Deficiency: An Unpredictable Defect With Wide Clinical and Immunologic Phenotype.

Scandinavian journal of immunology·2026

Evolution and Mechanistic Insights of Immunometabolism in Metabolic Diseases and Infections.

Scandinavian journal of immunology·2026

From Validation to Clinical Interpretation: A Flow Cytometric Th17-Cell Assay for STAT1- and STAT3-Related Inborn Errors of Immunity.

Scandinavian journal of immunology·2026

Impact of CD38 Deficiency on B Cell Development in CD19-Deficient Mice.

Scandinavian journal of immunology·2026

Decreased PD-1+ NK and T Cell Populations in Peritoneal Fluid contribute to Immune Dysregulation in Endometriosis.

Scandinavian journal of immunology·2026

Impact of Bacterial Membrane Vesicles on Cellular Responses in Leishmania amazonensis-Infected Macrophages In Vitro.

Scandinavian journal of immunology·2026

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us